The rising use of electronic cigarettes – essentially a nicotine delivery system using vapors from heated fluid instead of smoke – has attracted regulatory scrutiny on both sides of the Atlantic. However, in a move that some say could be a road map for US efforts to control e-cigs, European lawmakers have decided against regulating the devices as a medicine. Wall Street analysts have predicted the e-cigs could be a $1.7 billion market in the US this year.

Read more in the New York Times